During the past decade, Sotiria General Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 16 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 10 clinical trials were completed. i.e. 76.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sotiria General Hospital" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Amgen" with 5 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Bristol-Myers Squibb" with 5 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sotiria General Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Sotiria General Hospital" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Lung Cancer" (4 trials), "Non-Small Cell Lung Cancer" (4 trials), "Non Small Cell Lung Cancer" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Sotiria General Hospital" in a lesser frequency.

Most popular intervention types in "Sotiria General Hospital" are "Drug" (38 trials), "Other" (3 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Carboplatin" (7 trials), "Pemetrexed" (7 trials), "Cisplatin" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Sotiria General Hospital" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Sotiria General Hospital". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Sotiria General Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sotiria General Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".